Nalbuphine

  • TRADE NAMES: Bufigen; Nalcryn SP; Nubain (Endo); Nubain SP
  • INDICATIONS: Moderate to severe pain
  • CLASS: Opiate agonist
  • HALF-LIFE: 5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

CNS depressants, Diazepam, Hydrocodone, Hydromorphone, Oxymorphone, Pentobarbital, Promethazine, Tapentadol

PREGNANCY CATEGORY: B

Nalbuphine contains sulfites.

Our database has 15 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
LOCAL.


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top